Circulating tumor DNA (ctDNA) has shown promising results in monitoring and targeting cancer-specific mutations, most often in patients with advanced cancers. Join professionals from across the Rocky Mountains for a one-hour symposium that examines the use of ctDNA to detect, diagnose, and guide the treatment of tumors.
Dara Aisner, MD, PhD
Associate Professor; Physician
University of Colorado Hospital, UCHealth-Oncology Services